Filing Flows › Hinge Health (HNGE) › Guidance & outlook
Hinge Health (HNGE) guidance and outlook
Hinge Health (HNGE) raised its guidance on Nov 2, 2026: Revenue $880M for FY2026; Revenue +50% for FY2026; Operating income $266M–$268M for Q4 2026; Operating income +123% for Q4 2026.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $880M | raised |
| Revenue | FY2026 | +50% | raised |
| Operating income | Q4 2026 | $266M–$268M | raised |
| Operating income | Q4 2026 | +123% | raised |
| Operating margin | Q4 2026 | 30% | raised |
| Operating margin | Q4 2026 | +1000 bps | raised |
| Tax rate | FY2026 | 24% | reaffirmed |
From the earnings release filed Nov 2, 2026 (8-K on EDGAR).
Hinge Health's latest quarter
Hinge Health, Q3 2026: revenue $235M (+52% year over year), operating margin 21.4%, net earnings $57.4M, operating cash flow $115M. The chart follows the revenue to costs, profit and cash.
Questions
Did Hinge Health raise or lower its guidance?
Hinge Health (HNGE) raised its guidance on Nov 2, 2026: Revenue $880M for FY2026; Revenue +50% for FY2026; Operating income $266M–$268M for Q4 2026; Operating income +123% for Q4 2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.